Exclude Patient Type Detail Header
Yes
Footnote
<sup>1</sup> Lantus. Prescribing information. sanofi-aventis U.S. LLC; 2022.<br><br>
<sup>2</sup> Toujeo. Prescribing information. sanofi-aventis U.S. LLC; 2022.<br><br>
<sup>3</sup> Xultophy 100/3.6 Prescribing information. Novo Nordisk Inc.; 2022.<br><br>
<sup>4</sup> Soliqua 100/33. Prescribing information. sanofi-aventis U.S. LLC; 2022.
<sup>2</sup> Toujeo. Prescribing information. sanofi-aventis U.S. LLC; 2022.<br><br>
<sup>3</sup> Xultophy 100/3.6 Prescribing information. Novo Nordisk Inc.; 2022.<br><br>
<sup>4</sup> Soliqua 100/33. Prescribing information. sanofi-aventis U.S. LLC; 2022.
Detail Type
Image
Detail Image
Patient Type Detail Header (Long)
Premixed insulins and insulin combinations